Christopher Stephen

Dr. Christopher Stephen


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in JAMA Neurology
Verified
Journal Article
Open access
PDF file
CSChristopher Stephen
Christopher Stephen
VFVicki Fung
Vicki Fung
CLCodrin I. Lungu
Codrin I. Lungu
AEAlberto J. Espay
Alberto J. Espay
Functional neurological disorders (FNDs) are a collection of neurological symptoms, such as gait difficulties, limb weakness, sensory and cognitive complaints, and abnormal movements that include dissociative or seizurelike episodes that are inconsistent and incongruent with the range of manifestations of other organic neurological disorders.1 As a result, patients with FNDs require an expert neurological evaluation, precluding an exclusionary approach to the diagnosis. Frequently, associated functional somatic disorders include irritable bowel syndrome, unexplained pain, atypical chest pain, multiple chemical sensitivity, and chronic fatigue syndrome.2 Functional neurological disorders are more common in women than in men and affect all age groups, including children (2%-10% of patients treated at pediatric neurology clinics).3

4 February 2021 in Frontiers in Neurology
Verified
Journal Article
Open access
PDF file
LFLucy Frucht
Lucy Frucht
DPDavid L. Perez
David L. Perez
JCJanet Callahan
Janet Callahan
JMJulie MacLean
Julie MacLean
PSPhillip C. Song
Phillip C. Song
CSChristopher Stephen
Christopher Stephen
Dystonia is a common movement disorder, involving sustained muscle contractions, often resulting in twisting and repetitive movements and abnormal postures. Dystonia may be primary, as the sole feature (isolated) or in combination with other movement disorders (combined dystonia), or as one feature of another neurological process (secondary dystonia). The current hypothesis is that dystonia is a disorder of distributed brain networks, including the basal ganglia, cerebellum, thalamus and the cortex resulting in abnormal neural motor programs. In comparison, functional dystonia (FD) may resemble other forms of dystonia (OD) but has a different pathophysiology, as a subtype of functional movement disorders (FMD). FD is the second most common FMD and amongst the most diagnostically challenging FMD subtypes. Therefore, distinguishing between FD and OD is important, as the management of these disorders is distinct. There are also different pathophysiological underpinnings in FD, with for example evidence of involvement of the right temporoparietal junction in functional movement disorders that is believed to serve as a general comparator of internal predictions/motor intentions with actual motor events resulting in disturbances in self-agency. In this article, we present a comprehensive review across the spectrum of FD, including oromandibular and vocal forms and discuss the history, clinical clues, evidence for adjunctive “laboratory-based” testing, pathophysiological research and prognosis data. We also provide the approach used at the Massachusetts General Hospital Dystonia Center toward the diagnosis, management and treatment of FD. A multidisciplinary approach, including neurology, psychiatry, physical, occupational therapy and speech therapy, and cognitive behavioral psychotherapy approaches are frequently required; pharmacological approaches, including possible targeted use of botulinum toxin injections and inpatient programs are considerations in some patients. Early diagnosis and treatment may help prevent unnecessary investigations and procedures, while facilitating the appropriate management of these highly complex patients, which may help to mitigate frequently poor clinical outcomes.

17 March 2021 in European Journal of Neurology
Verified
Journal Article
Open access
PDF file
EGEmilia Gatto
Emilia Gatto
RWRuth H. Walker
Ruth H. Walker
CGClaudio Gonzalez
Claudio Gonzalez
MCMartin Cesarini
Martin Cesarini
GCGiovanni Cossu
Giovanni Cossu
TSthe Rare Movement Disorders Study Group of the International Parkinson Disease, Movement Disorders Society
the Rare Movement Disorders Study Group of the International Parkinson Disease, Movement Disorders Society
Background and purpose: Despite enormous advances in identifying genetic variants responsible for many neurological diseases, access to genetic testing may be limited in clinical practice. The objective of this study was to assess worldwide access to genetic tests for movement disorders and factors impacting their utilization.Methods: The Rare Movement Disorders Study Group of the International Parkinson and Movement Disorder Society designed an online survey electronically mailed to all 7815 members.Results: Survey data completed by 1269 participants from 109 countries were analysed. Limited access to geneticists and genetic counsellors was reported in many world regions compared to Europe and North America. Availability of genetic testing was limited, with rates of access lower than 50%. Genetic testing for chorea was the most commonly available. For parkinsonism, dystonia, ataxia, hereditary spastic paraplegias and metabolic disorders, there was limited access to genetic testing in all countries compared to Europe and North America, with significant differences found for Africa, Central/South America, Asia. In many regions, genetic testing was supported by either private or public funding. Genetic testing was free of charge in Europe according to 63.5% of respondents. In North America, Africa, Central/South America, Asia and the Middle East access to free of charge genetic testing was by far significantly lower compared to Europe.Conclusions: This survey highlights difficulties in accessing genetic testing and individuals with expertise in genetics at the worldwide level. In addition, major disparities in genetic testing amongst world regions are highlighted, probably due to a variety of factors including financial barriers.

7 June 2019 in The Cerebellum
Verified
Journal Article
Closed access
PDF file
CSChristopher Stephen
Christopher Stephen
JSJeremy D. Schmahmann
Jeremy D. Schmahmann

21 February 2019 in Current Treatment Options in Neurology
Verified
Journal Article
Closed access
CSChristopher Stephen
Christopher Stephen
KBKate T. Brizzi
Kate T. Brizzi
MBMarc A. Bouffard
Marc A. Bouffard
PGPablo Gomery
Pablo Gomery
SSStacey L. Sullivan
Stacey L. Sullivan
JSJeremy D. Schmahmann
Jeremy D. Schmahmann

18 February 2020 in Neurology
Verified
Journal Article
Closed access
PDF file
CSChristopher Stephen
Christopher Stephen
DBDavid Balkwill
David Balkwill
PJPeter James
Peter James
EHElizabeth Haxton
Elizabeth Haxton
KSKenneth Sassower
Kenneth Sassower
RLRichard Lewis
Richard Lewis
Objective A cross-sectional study was performed to evaluate whether quantitative oculomotor measures correlate with disease severity in late-onset GM2 gangliosidosis (LOGG) and assess cognition and sleep as potential early nonmotor features. Methods Ten patients with LOGG underwent quantitative oculomotor recordings, including measurements of the angular vestibulo-ocular reflex (VOR), with results compared to age- and sex-matched controls. Disease severity was assessed by ataxia rating scales. Cognitive/neuropsychiatric features were assessed by the cerebellar cognitive affective syndrome (CCAS) scale, Cerebellar Neuropsychiatric Rating Scale, and sleep quality evaluated using subjective sleep scales. Results Oculomotor abnormalities were found in all participants, including 3/10 with clinically normal eye movements. Abnormalities involved impaired saccadic accuracy (5/10), abnormal vertical (8/10) and horizontal (4/10) pursuit, reduced optokinetic nystagmus (OKN) responses (7/10), low VOR gain (10/10), and impaired VOR cancellation (2/10). Compared to controls, the LOGG group showed significant differences in saccade, VOR, OKN, and visually enhanced VOR gains. Severity of saccadic dysmetria, OKN, and VOR fixation-suppression impairments correlated with ataxia scales (p < 0.05). Nine out of ten patients with LOGG had evidence of the CCAS (5/10 definite, 2/10 probable, 2/10 possible). Excessive daytime sleepiness was present in 4/10 and 8/10 had poor subjective sleep quality. Conclusions Cerebellar oculomotor abnormalities were present in all patients with LOGG, including those with normal clinical oculomotor examinations. Saccade accuracy (dorsal cerebellar vermis localization), fixation suppression, and OKN gain (cerebellar flocculus/paraflocculus localization) correlated with disease severity, suggesting that quantitative oculomotor measurements could be used to track disease progression. We found evidence of the CCAS, suggesting that cerebellar dysfunction may explain the cognitive disorder in LOGG. Sleep impairments were prevalent and require further study.